These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6813492)

  • 1. Comparative pharmacology and biological effects of different gold compounds.
    Walz DT; DiMartino MJ; Griswold DE
    J Rheumatol Suppl; 1982; 8():54-60. PubMed ID: 6813492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of auranofin, an oral chrysotherapeutic agent.
    Delafuente JC; Osborn TG
    Clin Pharm; 1984; 3(2):121-7. PubMed ID: 6426843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of action of auranofin: effects on humoral immune response.
    Walz DT; Dimartino MJ; Griswold DE
    J Rheumatol Suppl; 1982; 8():32-6. PubMed ID: 6813489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarthritic properties and unique pharmacologic profile of a potential chrysotherapeutic agent: S K & F D-30162.
    Walz DT; DiMartino MJ; Chakrin LW; Sutton BM; MISHER A
    J Pharmacol Exp Ther; 1976 Apr; 197(1):142-52. PubMed ID: 772185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacological profile of auranofin, an orally active gold compound.
    Walz DT; DiMartino MJ; Griswold DE
    Scand J Rheumatol Suppl; 1983; 51():16-25. PubMed ID: 6426049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic actions and pharmacokinetic studies of auranofin.
    Walz DT; DiMartino MJ; Griswold DE; Intoccia AP; Flanagan TL
    Am J Med; 1983 Dec; 75(6A):90-108. PubMed ID: 6318557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics of parenteral and oral gold compounds.
    Gottlieb NL
    J Rheumatol Suppl; 1982; 8():99-109. PubMed ID: 6813498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pharmacology of gold compounds].
    Juan H
    Wien Klin Wochenschr Suppl; 1984; 156():7-13. PubMed ID: 6442062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chrysotherapy on cell mediated immune response.
    Lorber A; Jackson WH; Simon TM
    J Rheumatol Suppl; 1982; 8():37-45. PubMed ID: 6813490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gold and thiol compounds in the treatment of rheumatoid arthritis: excretory fate and tissue distribution of thiomalate in relation to gold after administration of myocrisin (auro-thiomalate).
    Jellum E; Munthe E; Guldal G; Aaseth J
    Scand J Rheumatol Suppl; 1979; (28):28-36. PubMed ID: 109914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience and rationale of monitoring plasma levels of gold in rheumatoid arthritis.
    Lorber A
    Agents Actions Suppl; 1981; 8():539-73. PubMed ID: 6781239
    [No Abstract]   [Full Text] [Related]  

  • 12. Gold-induced reactive oxygen species (ROS) do not mediate suppression of monocytic mitochondrial or secretory function.
    Omata Y; Lewis JB; Lockwood PE; Tseng WY; Messer RL; Bouillaguet S; Wataha JC
    Toxicol In Vitro; 2006 Aug; 20(5):625-33. PubMed ID: 16377126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro effects of gold salts on lymphocyte transformation responses and antibody dependent cell-mediated cytotoxicity.
    Davis P; Percy JS; Russell AS
    J Rheumatol; 1979; 6(5):527-33. PubMed ID: 118255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambivalent properties of gold drugs in adjuvant induced polyarthritis in rats.
    Garrett IR; Whitehouse MW; Vernon-Roberts B; Brooks PM
    J Rheumatol; 1985 Dec; 12(6):1079-82. PubMed ID: 3937896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of gold in rat blood after intravenous administration of auranofin, gold sodium thiomalate and aurothioglucose to rats.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1983 Feb; 10(1):117-20. PubMed ID: 6405031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gold therapy in rheumatoid arthritis. Interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin.
    Menard HA; Beaudet F; Davis P; Harth M; Percy JS; Russell AS; Thompson JM
    J Rheumatol Suppl; 1982; 8():179-83. PubMed ID: 6813482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of auranofin and other gold complexes on the activity of phospholipase C.
    Snyder RM; Mirabelli CK; Clark MA; Ziegler JT; Crooke ST
    Mol Pharmacol; 1987 Sep; 32(3):437-42. PubMed ID: 3118179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative evaluation of the physical and chemical properties of gold compounds.
    Sadler PJ
    J Rheumatol Suppl; 1982; 8():71-8. PubMed ID: 6813494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of gold in serum erythrocytes and white blood cells after in vitro incubation and during chrysotherapy with different gold compounds.
    Herrlinger JD; Alsen C; Beress R; Hecker U; Weikert W
    J Rheumatol Suppl; 1982; 8():81-9. PubMed ID: 6813496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte dependent excited oxygen radical generation in rheumatoid arthritis: inhibition by gold sodium thiomalate.
    Harth M; Keown PA; Orange JF
    J Rheumatol; 1983 Oct; 10(5):701-7. PubMed ID: 6315936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.